Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis has announced a partnership with Cogent International Manufacturing to launch a new CBD lozenge in the Canadian medical cannabis market. This collaboration, focused on leveraging patient feedback and real-world data, could lead to the future commercialization of additional medical cannabis products from Vectura Fertin Pharma in Canada. The agreement extends for two years and involves minimal capital investment from Aurora, with a revenue-sharing model on product sales.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
